BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16165135)

  • 41. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

  • 42. Examination of the rebound effect of biphasic oral contraceptives.
    Kovács I
    Ther Hung; 1990; 38(3):110-3. PubMed ID: 2284619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contraception and therapy with Tri Regol tablet.
    Adám J
    Ther Hung; 1991; 39(2):75-7. PubMed ID: 1948781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency and treatment of ovarian cysts in adolescence.
    Porcu E; Venturoli S; Dal Prato L; Fabbri R; Paradisi R; Flamigni C
    Arch Gynecol Obstet; 1994; 255(2):69-72. PubMed ID: 8092888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A clinical study of the triphasic contraceptive Tri-Regol].
    Rachev E
    Akush Ginekol (Sofiia); 1995; 34(2):64-5. PubMed ID: 8651433
    [No Abstract]   [Full Text] [Related]  

  • 46. [Medication of the month. Lowette, a contraceptive for treating acne in young women].
    Goffin V; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2003 Apr; 58(4):261-3. PubMed ID: 12868331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
    Charitidou C; Farmakiotis D; Zournatzi V; Pidonia I; Pegiou T; Karamanis N; Hatzistilianou M; Katsikis I; Panidis D
    Atherosclerosis; 2008 Feb; 196(2):958-65. PubMed ID: 17418849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Regulon in the treatment of hyperandrogenism in teenage girls].
    Mkrtchian MIa; Arustamian KK; Totoian ES; Mirzoian AS; Simonian DA
    Georgian Med News; 2006 Oct; (139):23-5. PubMed ID: 17077459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive.
    Van Trappen Y; Duvivier P; Thiery M; Van Kets H; Defoort P; Parewijck W; Derom R; Kermans G; Schoofs P
    Arzneimittelforschung; 1989 Jun; 39(6):717-9. PubMed ID: 2528355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
    Seidman L; Kroll R; Howard B; Ricciotti N; Hsieh J; Weiss H
    Contraception; 2015 Jun; 91(6):495-502. PubMed ID: 25746294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
    Zemtsov A; Wilson L
    Arch Dermatol; 1997 Apr; 133(4):431-3. PubMed ID: 9126004
    [No Abstract]   [Full Text] [Related]  

  • 52. [The desogestrel-ethinyl estradiol combination and overweight: current data].
    Rubio Lotvin B
    Ginecol Obstet Mex; 1995 Nov; 63():483-6. PubMed ID: 8537039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic urticaria and irregular menstrual cycle: a case report of effective therapy with oral contraception.
    Kasperska-Zając A; Zamlynski J
    J Dermatolog Treat; 2012 Apr; 23(2):159-60. PubMed ID: 20964573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis.
    Razzi S; Luisi S; Ferretti C; Calonaci F; Gabbanini M; Mazzini M; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):188-90. PubMed ID: 16963174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficiency of GnRH analogues in treating large functional ovarian cysts.
    Zervoudis S; Iatrakis G; Tomara E; Bothou A; Peitsidis P; Mastorakos G
    Clin Exp Obstet Gynecol; 2016; 43(2):230-2. PubMed ID: 27132416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evolution and future of contraception].
    Cagnacci A; Ferrari S
    Minerva Ginecol; 2010 Aug; 62(4):303-17. PubMed ID: 20827248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunogenicity of synthetic sex hormones and thrombogenesis].
    Beaumont V; Beaumont JL
    Pathol Biol (Paris); 1985 Apr; 33(4):245-9. PubMed ID: 3892453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conservative management of small postmenopausal cystic masses.
    Goldstein SR
    Clin Obstet Gynecol; 1993 Jun; 36(2):395-401. PubMed ID: 8513633
    [No Abstract]   [Full Text] [Related]  

  • 60. Laparoscopic management of ovarian cysts in a Hungarian county hospital.
    Varga T; Bódis J; Török A
    Hum Reprod; 1998 Dec; 13(12):3575-6. PubMed ID: 9886553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.